White House Considers Former Deputy Surgeon General for CDC Leadership The White House is evaluating Erica Schwartz, a former deputy surgeon general, as a potential nominee to lead the Centers for Disease Control and Prevention (CDC). According to two sources familiar with the process, Schwartz has emerged as the leading candidate for the position, which has remained vacant since the ouster of Susan Monarez in August 2025. The search for a permanent director has been complicated by the ongoing efforts of Health Secretary Robert F. Kennedy Jr. to restructure the federal health bureaucracy, including significant cuts to public health agencies and controversial vaccine policies. Schwartz’s nomination follows a prolonged selection process involving key figures within the Department of Health and Human Services. Chris Klomp, a top official in the department, and Kennedy have reportedly settled on Schwartz as their preferred candidate. However, the final approval from President Trump remains pending, with an announcement potentially occurring as early as April 15, 2026. If confirmed, Schwartz would become the first CDC director with a background in public health and a career in uniformed service, marking a shift from the political appointments that have characterized the agency’s leadership in recent years. Schwartz’s qualifications include her role as deputy surgeon general during the first Trump administration, where she oversaw critical public health initiatives. She also spent 24 years in the military, rising to the rank of rear admiral in the Coast Guard, where she served as the chief medical officer. Her academic background includes a medical degree from Brown University and a law degree from the University of Maryland.#white_house #department_of_health_and_human_services #robert_f_kennedy_jr #centers_for_disease_control_and_prevention #erica_schwartz
Trump Nominates Erica Schwartz as CDC Director President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, marking the culmination of a months-long effort to appoint a permanent leader to the agency amid ongoing leadership instability. The nomination follows a period of significant turmoil at the CDC, which has experienced multiple leadership changes and internal challenges under the oversight of Health and Human Services Secretary Robert F. Kennedy Jr. Schwartz’s nomination requires Senate confirmation, a process that will determine her ability to assume the role. The CDC has been operating under an acting director since Dr. Jay Bhattacharya’s tenure ended last month, as federal law—the Vacancies Act—prohibits acting officials from serving beyond 210 days without Senate approval. This legal constraint became critical in late August when the 210-day limit expired, prompting the need for a new nominee. The agency’s leadership upheaval has been compounded by the abrupt dismissal of its previous director, Dr. Susan Monarez, who was fired in August 2025. Monarez, the only confirmed CDC director during Trump’s second term, held the position for less than a month before being removed. In congressional testimony earlier that year, she stated she was terminated after refusing to endorse vaccine recommendations she deemed scientifically unsound. Her firing occurred amid heightened tensions between the agency and Kennedy Jr., who has been a vocal critic of public health policies, including vaccine mandates. The CDC’s instability has also been exacerbated by a series of events that have shaken its workforce and public confidence.#president_donald_trump #robert_f_kennedy_jr #centers_for_disease_control_and_prevention #kaiser_family_foundation #erica_schwartz
